The Pharma Exec behind the First Approved Gene Therapy Is Hunting for His Next Big Break
Novartis’s retiring CEO hopes such treatments will soon be deployed against lymphoma, other cancers
-- Read more on ScientificAmerican.com
Source: Scientific American - Category: Science Authors: Karen Weintraub Tags: Health Biotech Medicine Biology Source Type: research
More News: Biology | Biotechnology | Cancer | Cancer & Oncology | Gene Therapy | Genetics | Lymphoma | Pharmaceuticals | Science